• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿脊髓性肌萎缩症患者潜在心肌病的新视角——一项年龄匹配对照研究

New Perspectives of Underlying Cardiomyopathy in Pediatric SMA Patients-An Age Matched Control Study.

作者信息

Nicolae Georgiana, Capitanescu Andrei, Leanca Madalina Cristina, Neagu Elena, Vasile Daniela, Filip Cristina, Cinteza Eliza, Aria Amelia, Pavlov Bianka Maria, Uscoiu Gabriela, Raita Cristiana Ioana, Mirea Andrada

机构信息

Faculty of Midwifery and Nursing, "Carol Davila" University of Medicine and Pharmacy, 020021, Bucharest, Romania.

"Dr. Nicolae Robanescu" Children's Rehabilitation Center, 041408, Bucharest, Romania.

出版信息

Life (Basel). 2025 Jul 11;15(7):1091. doi: 10.3390/life15071091.

DOI:10.3390/life15071091
PMID:40724593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12298988/
Abstract

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder primarily affecting motor neurons. Emerging evidence suggests it also involves multiple organs, including potential cardiac manifestations. This study aimed to evaluate cardiac abnormalities in pediatric SMA patients compared to age-matched healthy controls, providing insight into underlying cardiomyopathy in this population. A total of 126 children were included in the study, with 63 SMA patients and 63 age-matched controls. We conducted clinical examinations, standard electrocardiography (ECG), and cardiac ultrasound (CUS) in all patients. Electrocardiographic analysis revealed a higher prevalence of sinus tachycardia in the SMA group and significantly deeper Q waves, indicating possible myocardial involvement. Echocardiographic findings demonstrated a significant reduction in left ventricular mass and left ventricular mass index in SMA patients compared to controls, despite normal systolic function. Statistical analysis confirmed that SMA diagnosis was an independent predictor of reduced myocardial mass, suggesting a distinct cardiac phenotype in SMA patients. This study provides new evidence of subclinical cardiac involvement in SMA, characterized by reduced myocardial mass, altered electrocardiographic parameters, and increased sinus tachycardia. These findings suggest a previously unrecognized form of cardiomyopathy in SMA that differs from cardiac manifestations typically seen in other neuromuscular disorders.

摘要

脊髓性肌萎缩症(SMA)是一种主要影响运动神经元的遗传性神经肌肉疾病。新出现的证据表明,它还涉及多个器官,包括潜在的心脏表现。本研究旨在评估与年龄匹配的健康对照相比,小儿SMA患者的心脏异常情况,以深入了解该人群潜在的心肌病。共有126名儿童纳入研究,其中63名SMA患者和63名年龄匹配的对照。我们对所有患者进行了临床检查、标准心电图(ECG)和心脏超声(CUS)检查。心电图分析显示,SMA组窦性心动过速的患病率较高,Q波明显更深,提示可能存在心肌受累。超声心动图结果显示,与对照组相比,SMA患者的左心室质量和左心室质量指数显著降低,尽管收缩功能正常。统计分析证实,SMA诊断是心肌质量降低的独立预测因素,提示SMA患者存在独特的心脏表型。本研究提供了SMA亚临床心脏受累的新证据,其特征为心肌质量降低、心电图参数改变和窦性心动过速增加。这些发现提示SMA中存在一种以前未被认识的心肌病形式,与其他神经肌肉疾病中常见的心脏表现不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f7/12298988/c838fa8f5b65/life-15-01091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f7/12298988/740d3c492538/life-15-01091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f7/12298988/c838fa8f5b65/life-15-01091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f7/12298988/740d3c492538/life-15-01091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f7/12298988/c838fa8f5b65/life-15-01091-g002.jpg

相似文献

1
New Perspectives of Underlying Cardiomyopathy in Pediatric SMA Patients-An Age Matched Control Study.小儿脊髓性肌萎缩症患者潜在心肌病的新视角——一项年龄匹配对照研究
Life (Basel). 2025 Jul 11;15(7):1091. doi: 10.3390/life15071091.
2
Spinal Muscular Atrophy脊髓性肌萎缩症
3
Quantitative assessment of muscle atrophy and structural changes in children with spinal muscular atrophy using ultrasound imaging.利用超声成像对脊髓性肌萎缩症患儿的肌肉萎缩和结构变化进行定量评估。
Eur J Paediatr Neurol. 2025 Jul;57:1-6. doi: 10.1016/j.ejpn.2025.04.013. Epub 2025 May 19.
4
Real-world outcomes of spinal muscular atrophy treatment with onasemnogene abeparvovec in Croatia: a comprehensive case series and literature review.克罗地亚使用onasemnogene abeparvovec治疗脊髓性肌萎缩症的真实世界结果:综合病例系列及文献综述
Front Med (Lausanne). 2025 Jun 24;12:1609072. doi: 10.3389/fmed.2025.1609072. eCollection 2025.
5
Systematic Review and Meta-analysis of Long-Term Nusinersen Effectiveness in Adolescents and Adults with Spinal Muscular Atrophy.脊髓性肌萎缩症青少年及成人长期使用诺西那生钠有效性的系统评价与荟萃分析
Adv Ther. 2025 Jun 27. doi: 10.1007/s12325-025-03260-1.
6
Systemic Inflammatory Response Syndrome全身炎症反应综合征
7
Autosomal Dominant Disorders常染色体显性疾病
8
Patient education in the management of coronary heart disease.冠心病管理中的患者教育
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3.
9
Cardiac pathology in spinal muscular atrophy: a systematic review.脊髓性肌萎缩症的心脏病理学:一项系统综述
Orphanet J Rare Dis. 2017 Apr 11;12(1):67. doi: 10.1186/s13023-017-0613-5.
10
AI-based Hepatic Steatosis Detection and Integrated Hepatic Assessment from Cardiac CT Attenuation Scans Enhances All-cause Mortality Risk Stratification: A Multi-center Study.基于人工智能的心脏CT衰减扫描检测肝脂肪变性及综合肝脏评估可增强全因死亡风险分层:一项多中心研究
medRxiv. 2025 Jun 11:2025.06.09.25329157. doi: 10.1101/2025.06.09.25329157.

本文引用的文献

1
Cardiac function evaluation in children with spinal muscular atrophy: A case-control study.脊髓性肌萎缩症患儿心功能评估:病例对照研究。
Pediatr Int. 2024 Jan-Dec;66(1):e15769. doi: 10.1111/ped.15769.
2
Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence.脊髓性肌萎缩症(5q SMA)患儿管理的疾病修正治疗:新出现证据的更新。
Drug Des Devel Ther. 2022 Jun 16;16:1865-1883. doi: 10.2147/DDDT.S214174. eCollection 2022.
3
Effect of Preterm Birth on Cardiac and Cardiomyocyte Growth and the Consequences of Antenatal and Postnatal Glucocorticoid Treatment.
早产对心脏和心肌细胞生长的影响以及产前和产后糖皮质激素治疗的后果。
J Clin Med. 2021 Aug 30;10(17):3896. doi: 10.3390/jcm10173896.
4
Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron Disease.颠覆脊髓性肌萎缩症仅仅是运动神经元疾病这一范式。
Pediatr Neurol. 2020 Aug;109:12-19. doi: 10.1016/j.pediatrneurol.2020.01.003. Epub 2020 Jan 22.
5
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey?脊髓性肌萎缩症的诊断之旅:是否仍充满曲折?
PLoS One. 2020 Mar 23;15(3):e0230677. doi: 10.1371/journal.pone.0230677. eCollection 2020.
6
The Preterm Heart in Childhood: Left Ventricular Structure, Geometry, and Function Assessed by Echocardiography in 6-Year-Old Survivors of Periviable Births.围产前期心脏在儿童期:应用超声心动图评估近足月产存活者 6 岁时左心室结构、几何形状和功能。
J Am Heart Assoc. 2018 Jan 20;7(2):e007742. doi: 10.1161/JAHA.117.007742.
7
Downregulation of Survivin contributes to cell-cycle arrest during postnatal cardiac development in a severe spinal muscular atrophy mouse model.Survivin 的下调导致严重脊髓性肌萎缩症小鼠模型出生后心脏发育过程中的细胞周期停滞。
Hum Mol Genet. 2018 Feb 1;27(3):486-498. doi: 10.1093/hmg/ddx418.
8
Natural history of infantile-onset spinal muscular atrophy.婴儿型脊髓性肌萎缩症的自然病史。
Ann Neurol. 2017 Dec;82(6):883-891. doi: 10.1002/ana.25101. Epub 2017 Dec 8.
9
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.依库珠单抗治疗婴儿型脊髓性肌萎缩症的疗效观察
N Engl J Med. 2017 Nov 2;377(18):1723-1732. doi: 10.1056/NEJMoa1702752.
10
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.脊髓性肌萎缩症的单剂量基因治疗。
N Engl J Med. 2017 Nov 2;377(18):1713-1722. doi: 10.1056/NEJMoa1706198.